A Study to Evaluate the Efficacy, Immune Response, and Safety of a COVID-19 Vaccine in Adults ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to<18 Years) at Risk for SARS-CoV-2

Clinical trial NCT04611802 · COMPLETED

Trial details

NCT number: NCT04611802
Sponsor: Novavax
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

SARS-CoV Infection Covid19

Start date: 2020-12-27
Primary completion: 2023-04-10
Enrollment: 33000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.